The contract aims to support EFSA’s emerging risk identification by prioritising and analysing the composition of food supplements made of plants reported to contain substances with QSAR-predicted carcinogenic, mutagenic or reprotoxic properties. The work will build on existing EFSA and Member State activities and help EFSA and Member Stated competent authorities to decide how to follow-up on this issue.